Hungary

News from Hungary

Find out more about Bayer's operations in Hungary. Read our news, our press releases.

 

The sale of Bayer Animal Health's business to Elanco has been completed

(August 3, 2020)

The transaction, in which Bayer sold its Animal Health business to Elanco Animal Health Incorporated in the United States, was completed. The two companies signed an agreement to that effect last August. The transaction could be completed after the fulfilment of the conditional requirements, thus obtaining the official approvals.

Read more on local language

 

Bayer Hungaria Kft. provides health protection equipment to eleven institutions in the value of twenty million HUF

(June 10, 2020)

The coronavirus pandemic has drawn attention to its longer-term nature, a solution must also be found for health and social institutions to defend themselves against the dangers posed by viruses. Bayer Hungaria Kft. with the Hungarian Interchurch Aid organization intends to support social and hospital institutions for the care of those at risk. By donating to 11 locations in the country the Clinical Oncology Department of the Teaching Hospital Mor Kaposi from Somogy County is also benefited.

Read more on local language

 

Employees of Bayer Hungaria Kft. collected Christmas donations for organizations helping those in need and patients

(December 19, 2018)

Krisztina Karpat, the managing director of Bayer Hungaria Kft., handed over seventy gift boxes to Tibor Hari, the Director of the Hungarian Baptist Aid at the ‘Shoe Box Castle’ in Deak Square on 12 December. The gift boxes were assembled, packaged and labelled by the employees of Bayer Hungaria Kft. for children in need. In addition to the Baptists, the company also supported the Day Care Institute for Disabled in Szeged and the ‘Miracle Lamp’ Foundation.

Read more on local language

 

Bayer aims to consolidate key life sciences businesses and significantly improve productivity and profitability

(December 4, 2018)

The Bayer Group is preparing to consolidate its key life sciences businesses through a series of portfolio efficiency and structural measures aimed at increasing productivity and innovation while significantly improving competitiveness. At its meeting on 29 November, the Supervisory Board of Bayer AG discussed the plans developed by the Board of Directors and unanimously supported them. Through these measures, the company will pave the way for sustainable business success in attractive, long-term growth markets.

Read more on local language

 

Press contact:

Marianna Nagy, Communication Specialist

Phone: +36 (30) 886 1473

E-mail: marianna.nagy@bayer.com

We recommend the Bayer magazine News & Stories, which provides an interesting overview of Bayer 's life sciences activities in digital form.

Why is it so exciting to work at Bayer? How can doctors help their patients with innovative products? How do Bayer’s innovations support farmers in feeding humanity around the world?

click here